Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
95% CI 1.76 to 2.29) for 10% weight reduction
A 2022 review of semaglutide as a treatment for overweight and obesity recorded an average reduction in body weight of 14.44% in STEP clinical trial participants after 68 weeks of 2.4mg weekly injections
GLP-1s also activate receptors in the hypothalamus area of the brain (the control center for hunger and thirst) to curb appetite
Generally, most patients start on semaglutide because of the lower risk of GI side effects
How much weight do people lose while taking weight-loss drugs
Once approved, the patient is seated comfortably while a healthcare provider inserts an intravenous line into a vein, usually in the arm
